Tag: upadacitinib

All

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo

If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.

All

Sorry, No Posts Found

All

‘Plastic Surgery Deserts’ Emerging as Demand Grows in Underserved US Regions

An analysis of national search trends and surgeon workforce data highlights rising patient interest in aesthetic procedures across Southern, Midwestern, and rural regions where access to board-certified plastic surgeons remains limited.

Survey Finds Americans Prioritizing Aesthetic Treatments Over Everyday Spending
Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
Phase 4 Study Reports High Opioid-Free Recovery Rates With Journavx After Plastic Surgery

Tag: upadacitinib

All

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo

All

Sorry, No Posts Found

All

‘Plastic Surgery Deserts’ Emerging as Demand Grows in Underserved US Regions

Survey Finds Americans Prioritizing Aesthetic Treatments Over Everyday Spending

Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards

Phase 4 Study Reports High Opioid-Free Recovery Rates With Journavx After Plastic Surgery

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links